Clinical trial
Multicenter Therapy Study for Children With Mature B-NHL or B-ALL With a Rituximab - Window Before Chemotherapy
NCT00324779 is registered in ClinicalTrials.gov with University Hospital Erlangen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Therapy Study for Children With Mature B-NHL or B-ALL With a Rituximab - Window Before Chemotherapy
- Lead sponsor
- University Hospital Erlangen
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2004
- Completion date
- Not reported
- Enrollment
- 79 (estimated)
- Sites
- 38
Conditions
As the registry lists them; a condition with its own page is linked.